ÀÇ·á¹ýÀÎ ÀÌ¿øÀÇ·áÀç´Ü
EDTA tube
÷°¡Á¦ K2 EDTA
ÇØ´ç°Ë»ç CBC, ABO, Rh, ABO Subtyping, Diff Count, Eosinophil Count, ESR, DAT,Du test, Reti, Malaria, HbAIc, PB morphology
°Ëü·® 3mL
º¸°ü ¿ë±â: ½Ç¿Â, äÇ÷ ÈÄ ³ÃÀå
Âü°í»çÇ× Ã¤Ç÷ ÈÄ Ç×ÀÀ°íÁ¦¿Í ÃæºÐÈ÷ È¥ÇÕ

´Ý±â

°Ë»çÇ׸ñ

ÃֽŠ°Ë»çÇ׸ñ°ú °Ë»çÆÐ³ÎÀ» È®ÀÎÇÏ½Ç ¼ö ÀÖ½À´Ï´Ù.

°Ë»çÇ׸ñ Á¶È¸

BRAF mutation (Sequencing)

Àμâ
°Ë»çºÐ¾ß
ºÐÀÚÀ¯Àü°Ë»ç
: ºñÀ¯Àü¼º(somatic) À¯ÀüÀÚ °Ë»ç
°Ë»çÄÚµå
H0081
ºÐ·ù¹øÈ£
³ª583´Ù(1)
º¸ÇèÄÚµå
C5833066Z
°Ë»ç¹æ¹ý
Sequencing
°Ë»çÀÏ
¿ù,¼ö,±Ý
¼Ò¿äÀÏ
3ÀÏ

*Åä, ÀÏ, °øÈÞÀÏ ¹ÌÆ÷ÇÔ
°Ë»ç¼ö°¡
£Ü130,940

*Áú°¡»ê·á¸¦ Æ÷ÇÔÇÏÁö ¾Ê½À´Ï´Ù.
°ËüÁ¾·ù

EDTA tube

°Ëü·® 4mL
°Ëüº¸°ü ³ÃÀå
°Ëü¾ÈÁ¤¼º ½Ç¿Â: 1ÀÏ
³ÃÀå: 3ÀÏ
Âü°íÄ¡
ÀÓ»óÀûÀÇÀÇ BRAF À¯ÀüÀÚ´Â B type raf kinase¸¦ »ý¼ºÇϸç, ÀÌ À¯ÀüÀÚÀÇ º¯ÀÌ´Â °©»ó¼± À¯µÎ¾Ï, Èæ»öÁ¾, ´ëÀå¾Ï µî¿¡¼­ Á¾Á¾ °üÂûµÈ´Ù. BRAF µ¹¿¬º¯ÀÌÀÇ ´ëºÎºÐÀ» Â÷ÁöÇÏ´Â V600E º¯ÀÌ´Â °©»ó¼± À¯µÎ¾Ï ¹× Ç÷¾×¾Ï(hairy cell leukemia, Langerhans-cell histiocytosis)ÀÇ Áø´Ü¿¡ ÀÌ¿ëµÉ ¼ö ÀÖ´Ù. ¶ÇÇÑ KRASÀÇ wild typeÀÎ ´ëÀå¾Ï¿¡¼­ BRAF À¯ÀüÀÚÀÇ º¯ÀÌ´Â Ç× EGFR Ç×ü °è¿­ÀÇ Ç×¾ÏÁ¦(cetuximab, panitumumab)¿¡ ¹ÝÀÀÇÏÁö ¾Ê´Â ¾à¹°ÀúÇ×¼ºÀÇ ¿¹ÃøÀÎÀÚÀÌ´Ù. ÀÌ °Ë»ç´Â BRAF À¯ÀüÀÚ exon 15ÀÇ codon 600 ÁÖº¯ÀÇ ¿°±â¼­¿­À» ºÐ¼®ÇÏ¿©, BRAF V600E»Ó¸¸ ¾Æ´Ï¶ó ´Ù¸¥ µå¹® º¯À̵µ °ËÃâÇÒ ¼ö ÀÖ´Ù.
ÁÖÀÇ»çÇ× 1) FFPE section slide(unstained) 10¥ìm 5Àå + H&E slide 1Àå
2) ÀüÀ̼º ´ëÀåÁ÷Àå¾Ï ¾àÁ¦ ¼±Åà ¹× Ç÷¾×¾Ï Áø´Ü ¸ñÀû °Ë»ç ½Ã ±Þ¿©, ±× ¿Ü ºñ±Þ¿©
Çʼö¼­·ù À¯ÀüÀڰ˻絿ÀǼ­ºÐÀÚº´¸®Áø´ÜÀÇ·Ú¼­
ÃֽŰø¹® °ø¹®2024-012È£(°Ë»çÁ¤º¸ º¯°æ ¾È³»)